Clinical Trial

Study on the Immediate Analgesic Effect of Yanglingquan Acupoint Treatment for Biliary Colic

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Guided by traditional meridian and acupoint theory, conducting standardized, large-sample, multicenter randomized controlled trials (RCTs) to evaluate the clinical efficacy of pattern differentiation and meridian-based acupoint selection for biliary colic across multiple levels can provide high-quality research evidence for developing evidence-based guidelines or optimal treatment protocols. This holds significant importance for enhancing the clinical efficacy of acupuncture in treating biliary colic and promoting its widespread clinical application. Therefore, this study will conduct a multicenter, large-sample randomized controlled trial comparing the clinical effects of acupuncture at Yanglingquan (GB34) versus drug therapy for acute cholecystitis biliary colic. It aims to investigate the clinical efficacy and safety of acupuncture treatment for acute cholecystitis biliary colic.
Trial Details
NCT Number NCT07194655
Lead Sponsor First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Collaborators: Tianjin Medical University General Hospital, Tianjin Hospital of Integrated Traditional Chinese and Western Medicine
Conditions Biliary Colic
Enrollment 248 participants
Start Date 2025-10
Primary Completion 2026-10 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2025-09-26